Sahajanand Medi — 360° view

Sahajanand Medi, a company in the Medical Equipment & Supplies industry, reported revenue of ₹373 crore and net profit of ₹26 crore for the September 2026 quarter.

Sahajanand Medi (NSE: SMT) closed at ₹527.60 on 20 Nov 2026. Its market capitalisation is ₹5,363 crore and it trades at 74.7 times earnings.

Share price
₹527.60 (20 Nov 2026)
Market cap
₹5,363 Cr (20 Nov 2026)
P/E
74.68 (20 Nov 2026)
Revenue
₹373 Cr (September 2026 quarter)
Net profit
₹26 Cr (September 2026 quarter)
ROCE
11.4% (FY26)
ROE
10.4% (FY26)
Book value
₹ (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹578.70 / ₹346.65 (20 Nov 2026)
Sector
Healthcare
Industry
Medical Equipment & Supplies
Symbol
NSE: SMT

Sahajanand Medical Technologies Ltd (SMT) develops and manufactures Class III /Class C- D cardiovascular devices used in vascular and structural-heart interventions. Its main products include coronary stents and balloons, TAVI heart valves and congenital-heart occluders. It sold products across 77 countries in FY26.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.